Dual mechanism for toughening and sustained aminoglycoside elution from a polyphosphate hydrogel
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Introduction: Bacteria preferentially colonize biomaterial and medical device surfaces, often leading to the
formation of an exopolysaccharide matrix or biofilm, capable of increasing resistivity to antibiotics by up to 1000
fold.[1] As a result, infections in chronic wounds or on medical device surfaces may require hospital readmission,
long courses of high-dose antibiotics, revision surgeries, culminating in patient discomfort, increased morbidity
rates, and elevated health care costs.[2] Hydrogels have been explored as potential drug carriers with good
biocompatibility. A major drawback has been the weak, brittle nature of hydrogels. Here we report on a
polyphosphate hydrogel with a dual mechanism for both toughening and prolonging aminoglycoside drug release.
Materials and Methods: Polyphosphate hydrogels were formed by free radical polymerization of: methacrylated
poly(phosphoethyl-methacrylate-co-acrylic acid) polymer (6.5 wt %), acrylamide and bis-acrylamide (1 wt %) with
APS and TEMED as initiators. Hydrogels were then loaded with either 50 mM Ca2+, 5 mM tobramycin or a
combination of both. All loading solutions contained 150 mM NaCl and were pH adjusted to 7.7. Volume changes
during loading were measured by photography and image J software. Hydrogels were immersed in 130 mM NaCl,
plus 1.5 mM Mg2+ and 2.5 mM Ca2+ at pH 7.3, the solution was changed daily and tobramycin content measured
colorimetrically to determine the release behavior. The initial modulus was measured using an Instron 3342 material
test system and derived from the linear slope from the first 10% of compressive strain, errors are +/- 1 S.D., n=3.
P. aeruginosa ATCC 27853 biofilms were grown and CFU quantified using Clinical Laboratory and Standards
Institute (CLSI) standard protocols. Biofilms were exposed to tobramycin loaded hydrogels in a biomimetic flow
cell with flow rate of 5 mL/h and CFU’s counted after 24 and 72 h.

Figure 1: A) Cumulative release of tobramycin from
polyphosphate hydrogels. ~600 µg total elution with a
daily release above the measured P.Aeruginosa minimum
bactericidal concentration for greater than 50 days. B)
Initial modulus of polyphosphate hydrogels with Ca2+
(blue) and after tobramycin loading (red). Groupings
represent varying amounts of initial loaded Ca2+ and the
axis shows the final ratios of calcium to phosphate
following tobramycin loading. Error bars are +/- 1 S.D.,
n=3.

Results and Discussion: Both divalent metal cations and
positively charged drugs will electrostatically crosslink
phosphates in the hydrogel structure.[3] Hydrogels shrank
by ~50% after the addition of Ca2+ or tobramycin
antibiotic, resulting from dense metal-phosphate or drugphosphate crosslink formation.[3] Ca2+ has a toughening
effect resulting in a compressive modulus of 0.8 +/-0.07
MPa, Fig. 1B. This is similar to cartilage 0.7 MPa and
meniscus 0.2 MPa.[4,5] In contrast tobramycin loading
has a limited toughening effect, 0.04 +/- 0.01 MPa
compressive modulus, but results in prolonged release of
tobramycin above the measured MBC for P.Aeruginosa (2
µg/ml) for greater than 50 days, Fig 1A. The prolonged
release has been shown effective at total eradication of
P.Aeruginosa biofilms (9 log10 reduction) in a biomimetic
flow cell. Preliminary studies combining both Ca2+
crosslinks and tobramycin crosslinks in a single hydrogel
have resulted in a hydrogel that is both tough, compressive
modulus of 0.2 +/- 0.01 MPa, and maintains the prolonged
release profile for tobramycin.

Conclusion: Polyphosphate hydrogels with the dual toughening and drug releasing mechanism could be capable of
a structural role in arthroplasty procedures or as a protective bandage in wound care or surgery and still sustain local
release of antibiotics.
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